Cost analysis of teleretinal screening for diabetic retinopathy in a county hospital population

Diabetes Care. 2014 Dec;37(12):e252-3. doi: 10.2337/dc14-0929.

Authors

Anh-Danh T Phan¹, Jacob J Koczman², Chi-Wah Yung², Allison A Pernic², Eric D Doerr², Mark M Kaehr²

Affiliations

¹ Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, School of Medicine, Indiana University, Indianapolis, IN anphan@iupui.edu.
² Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, School of Medicine, Indiana University, Indianapolis, IN.

PMID: 25414394
DOI: 10.2337/dc14-0929

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cost-Benefit Analysis
Diabetic Retinopathy / diagnosis*
Diabetic Retinopathy / economics*
Diabetic Retinopathy / epidemiology
Hospitals, County
Humans
Indiana / epidemiology
Insurance / statistics & numerical data
Mass Screening / economics*
Mass Screening / methods*
Medicaid / statistics & numerical data
Medicare / statistics & numerical data
Telemedicine / economics*
United States / epidemiology